Update! Note the dates. Especially phase 2 data release.
$Armata Pharmaceuticals(ARMP.US$ Armata Pharmaceuticals Inc -Phase 2 Topline Data Anticipated in 2H 2024 Followed by Potential Initiation of a Pivotal Bronchiectasis Trial in 2025
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment